companydata.dkcompanydata.dk

New Cardiolab ApS: Financial statements 2022

CVR: 36895705

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

New Cardiolab ApS (CVR 36895705) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,192,181 and a net result of DKK 179,619 compared with DKK 516,376 the year before. That is an increase of 511.7% compared with the year before. Equity in the 2022 report amounted to DKK -495,609. The company had 5 employees in the financial year.

Gross Profit
DKK 1,192,181
Profit/Loss
DKK 179,619
Equity
DKK -495,609
Total Assets
DKK 1,207,505
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.2 mio.180 t.-496 t.5
2021-195 t.516 t.-675 t.3
2020-80 t.-34 t.-1.2 mio.1
2019-240 t.312 t.-1.2 mio.1
2018-172 t.-94 t.-1.5 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on New Cardiolab ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

New Cardiolab ApS: The 2021 annual report is outMar 9, 2022

New Cardiolab ApS has published its annual report for 2021. Gross profit came to DKK 194,894, and the net result was DKK 516,376.

About New Cardiolab ApS

New Cardiolab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2015. The company is registered under the industry Speciallægers aktiviteter. The management consists of Janet Alsø and Susan Alsø. The company is owned by Susan Alsø Holding ApS and Janet Alsø Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 1,878,462 and a net result of DKK 76,064 compared with DKK 1,099,197 the year before. Equity in the 2025 report amounted to DKK 300,501.

Source: annual report 2025, Danish Business Authority